Mechanisms underlying differential D1 versus D2 dopamine receptor regulation of inhibition in prefrontal cortex

J Neurosci. 2004 Nov 24;24(47):10652-9. doi: 10.1523/JNEUROSCI.3179-04.2004.

Abstract

Typically, D1 and D2 dopamine (DA) receptors exert opposing actions on intracellular signaling molecules and often have disparate physiological effects; however, the factors determining preferential activation of D1 versus D2 signaling are not clear. Here, in vitro patch-clamp recordings show that DA concentration is a critical determinant of D1 versus D2 signaling in prefrontal cortex (PFC). Low DA concentrations (<500 nm) enhance IPSCs via D1 receptors, protein kinase A, and cAMP. Higher DA concentrations (>1 microm) decrease IPSCs via the following cascade: D2-->G(i)-->platelet-derived growth factor receptor--> increase phospholipase C--> increase IP3--> increase Ca2+--> decrease dopamine and cAMP-regulated phosphoprotein-32--> increase protein phosphatase 1/2A--> decrease GABA(A). Blockade of any molecule in the D2-linked pathway reveals a D1-mediated increase in IPSCs, suggesting that D1 effects are occluded at higher DA concentrations by this D2-mediated pathway. Thus, DA concentration, by acting through separate signaling cascades, may determine the relative amount of cortical inhibition and thereby differentially regulate the tuning of cortical networks.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Cyclic AMP-Dependent Protein Kinases / physiology
  • Dopamine / pharmacology
  • Dopamine / physiology
  • Dose-Response Relationship, Drug
  • Electrophysiology
  • In Vitro Techniques
  • Mice
  • Mice, Inbred C57BL
  • Neural Inhibition / drug effects
  • Neural Inhibition / physiology*
  • Patch-Clamp Techniques
  • Prefrontal Cortex / drug effects
  • Prefrontal Cortex / physiology*
  • Pyramidal Cells / drug effects
  • Pyramidal Cells / physiology
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Dopamine D1 / physiology*
  • Receptors, Dopamine D2 / physiology*
  • Signal Transduction / physiology
  • gamma-Aminobutyric Acid / physiology

Substances

  • Receptors, Dopamine D1
  • Receptors, Dopamine D2
  • gamma-Aminobutyric Acid
  • Cyclic AMP-Dependent Protein Kinases
  • Dopamine